{"id":58943,"date":"2018-07-11T13:21:06","date_gmt":"2018-07-11T17:21:06","guid":{"rendered":"https:\/\/rarediseases.org\/fda-commissioner-dr-scott-gottlieb-confirmed-as-2018-nord-rare-summit-keynote-speaker\/"},"modified":"2018-07-11T13:21:06","modified_gmt":"2018-07-11T17:21:06","slug":"fda-commissioner-dr-scott-gottlieb-confirmed-as-2018-nord-rare-summit-keynote-speaker","status":"publish","type":"post","link":"https:\/\/rarediseases.org\/es\/fda-commissioner-dr-scott-gottlieb-confirmed-as-2018-nord-rare-summit-keynote-speaker\/","title":{"rendered":"FDA Commissioner Dr. Scott Gottlieb Confirmed as 2018 NORD Rare Summit Keynote Speaker"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-35078 alignleft\" src=\"https:\/\/rarediseases.org\/wp-content\/uploads\/2018\/07\/1200px-Scott_Gottlieb_official_portrait-240x300.jpg\" alt=\"1200px-Scott_Gottlieb_official_portrait\" width=\"240\" height=\"300\" \/>Dr. Scott Gottlieb was sworn in as the 23rd Commissioner of Food and Drug Administration in 2017, and provided a keynote speech at the NORD Rare Summit shortly thereafter. 2018 marks his second year at the Summit, and we look forward to Dr. Gottlieb&#8217;s update for the rare disease community.<\/p>\n<p>In addition to Dr. Gottlieb&#8217;s feature as the 2018 keynote speaker, there are plenty of reasons to register for the <a href=\"https:\/\/rarediseases.org\/summit-overview\/\" target=\"_blank\" rel=\"noopener\">2018 NORD Rare Diseases and Orphan Products Breakthrough Summit<\/a>! Here are\u00a0four additional reasons <em><strong>you shouldn&#8217;t miss this opportunity<\/strong><\/em>\u00a0to hear from experts and join the conversation about the new era of patient-focused innovation:<\/p>\n<p>In a special <strong>Patient Perspectives Panel<\/strong>, patients and caregivers will share their hopes, questions and concerns about gene therapy and how this potential game-changer is perceived in their communities.<\/p>\n<p>FDA senior staff will share their perspectives on the current status and future outlook for <strong>Patient-Focused Drug <\/strong>Development, and the implications for all stakeholders. Also, the division heads of CDER, CBER and CDRH will share insights and predictions for orphan product trends, opportunities and challenges.<\/p>\n<p>From artificial intelligence to facial recognition software, technology offers hope for addressing many rare disease challenges. We&#8217;ll explore some of these innovative approaches in an <strong>Embracing Innovation to Advance Science<\/strong> track.<\/p>\n<table class=\"galileo-ap-layout-editor\" border=\"0\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td class=\" editor-col OneColumnMobile\" align=\"\" valign=\"top\" width=\"100%\">\n<div class=\"gl-contains-text\">\n<table border=\"0\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td class=\"editor-text editor-text \" align=\"left\" valign=\"top\">\n<div class=\"text-container galileo-ap-content-editor\">\n<div>\n<div>\u00a0In addition to the content that we have packed into the 2018 NORD Rare Summit, attendees will be presented with\u00a0<strong>hundreds of networking opportunities\u00a0<\/strong>with some of the rare disease community&#8217;s top leaders.<\/div>\n<\/div>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table class=\"galileo-ap-layout-editor\" border=\"0\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td class=\"three-column editor-col OneColumnMobile\" align=\"left\" valign=\"top\" width=\"33%\">\n<div><\/div>\n<div class=\"gl-contains-image\">\n<table class=\"editor-image content-image\" border=\"0\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td align=\"center\" valign=\"top\">\n<div class=\"publish-container\"><img decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/files.constantcontact.com\/e0ab2096501\/56247edb-fce9-4060-8675-3f2ef331ba73.png\" alt=\"\" width=\"157\" border=\"0\" hspace=\"0\" vspace=\"0\" \/><\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/td>\n<td class=\"three-column editor-col OneColumnMobile\" align=\"left\" valign=\"top\" width=\"33%\">\n<div><\/div>\n<div class=\"gl-contains-image\">\n<table class=\"editor-image content-image editor-image-hspace-on\" border=\"0\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td align=\"center\" valign=\"top\">\n<div class=\"publish-container\"><img decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/files.constantcontact.com\/e0ab2096501\/c73e1756-ed6a-402d-b635-fe917351ef8b.png\" alt=\"\" width=\"180\" border=\"0\" hspace=\"0\" vspace=\"0\" \/><\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/td>\n<td class=\"three-column editor-col OneColumnMobile\" align=\"left\" valign=\"top\" width=\"33%\">\n<div class=\"gl-contains-image\">\n<table class=\"editor-image content-image editor-image-hspace-on\" border=\"0\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td align=\"right\" valign=\"top\">\n<div class=\"publish-container\"><img decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/files.constantcontact.com\/e0ab2096501\/cbc4ca53-5fc2-439b-ae57-c5c93f683e95.png\" alt=\"\" width=\"180\" border=\"0\" hspace=\"0\" vspace=\"0\" \/><\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: center;\"><a href=\"https:\/\/rarediseases.org\/summit-overview\/\" target=\"_blank\" rel=\"noopener\"><strong>Learn more and register\u00a0here<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Scott Gottlieb was sworn in as the 23rd Commissioner of Food and Drug Administration in 2017, and provided a keynote speech at the NORD Rare Summit shortly thereafter. 2018 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/rarediseases.org\/es\/fda-commissioner-dr-scott-gottlieb-confirmed-as-2018-nord-rare-summit-keynote-speaker\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> \u00abFDA Commissioner Dr. Scott Gottlieb Confirmed as 2018 NORD Rare Summit Keynote Speaker\u00bb<\/span><\/a><\/p>\n","protected":false},"author":47,"featured_media":12556,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[232,503,190,210,192,193],"tags":[1274,244,1332,212,1683,1496,200,1684,404,643,1682],"class_list":["post-58943","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy","category-events","category-featured-news","category-industry","category-patients-members","category-research","tag-dr-scott-gottlieb","tag-fda","tag-fda-commissioner","tag-gene-therapy","tag-keynote-speaker","tag-nord-rare-summit","tag-nord-summit","tag-patient-perspectives","tag-patient-focused-drug-development","tag-rare-diseases-and-orphan-products-breakthrough-summit","tag-u-s-food-and-drug-administration"],"acf":[],"_links":{"self":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/58943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/comments?post=58943"}],"version-history":[{"count":0,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/58943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/media\/12556"}],"wp:attachment":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/media?parent=58943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/categories?post=58943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/tags?post=58943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}